In this piece, Jennifer Goldsmith, Senior Vice President of Veeva
Vault Strategy, illustrates how an increasingly complex clinical
trial landscape is driving the life sciences industry to support broad
collaborations to define and implement common approaches that
make running a trial easier. These collaborations are becoming
a strategic priority for many companies hoping to create greater
efficiencies in the race to deliver innovative therapies, drugs, and
medicines to market faster. The industry is working together to
collectively define approaches that could create greater efficiencies
in trial processes, especially as sponsors increasingly outsource their
research and development work to CROs.